Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

21.15
Delayed Data
As of 4:01pm ET
 +0.15 / +0.71%
Today’s Change
10.85
Today|||52-Week Range
33.82
+11.61%
Year-to-Date
Should You Hold Momenta (MNTA) Stock in Your Portfolio?
11:40am / Zacks.com - Paid Partner Content
Eli Lilly's Cluster Headache Candidate Succeeds in Phase III
May 16 / Zacks.com - Paid Partner Content
Migraine Space in Focus as AMGN/NVS' Aimovig Gets FDA Nod
May 21 / Zacks.com - Paid Partner Content
Teva Stock Up 5% as Buffett's Berkshire Raises Stake in Q1
May 16 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Zoetis to Buy Abaxis, NVS Gets FDA Nod for Migraine Drug
May 18 / Zacks.com - Paid Partner Content
Novartis Multiple Sclerosis Drug Gets FDA Nod for Adolescents
May 14 / Zacks.com - Paid Partner Content
Amgen's Migraine Drug Aimovig Gets FDA Approval, Shares Up
May 18 / Zacks.com - Paid Partner Content
AstraZeneca's (AZN) Asthma Drug Fasenra Fails in COPD Study
May 14 / Zacks.com - Paid Partner Content
Company News For May 17, 2018
May 17 / Zacks.com - Paid Partner Content
BioDelivery (BDSI) Q1 Earnings and Sales Beat Estimates
May 11 / Zacks.com - Paid Partner Content